An Act to clarify prescription monitoring program activities
House: Accompanied a study order, see H5234
Email me when H 2502 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 2502. By continuing you agree to the Terms and Privacy Policy.
Summary
The measure amends the state law to exclude testosterone from the list of drugs tracked by the prescription monitoring program and orders the department to delete any existing testosterone prescribing data. It would affect doctors, pharmacies, and patients who use testosterone, as well as the Department of Public Health that runs the system. The change aims to clarify monitoring rules by no longer requiring testosterone to be reported.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 2502
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Accompanied a study order, see H5234
- Reporting date extended to Thursday, October 9, 2025
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Senate concurred
- Referred to the committee on Public Health
Sponsors
- John Francis Moran · sponsor
- Carmine Lawrence Gentile
- Mindy Domb
- Samantha Montaño
- Sean Garballey
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 2502 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 2502 freeOr ask your AI assistant about H 2502 directly:
Add to Claude, ChatGPT or Cursor